S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
MUST WATCH: Unusual 3-second financial maneuver (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
MUST WATCH: Unusual 3-second financial maneuver (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
MUST WATCH: Unusual 3-second financial maneuver (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
MUST WATCH: Unusual 3-second financial maneuver (Ad)
BATS:NURE

Nuveen Short-Term REIT ETF - NURE Stock Forecast, Price & News

$34.95
+0.28 (+0.81%)
(As of 08/8/2022 12:00 AM ET)
Add
Today's Range
$34.82
$35.19
50-Day Range
$31.24
$35.64
52-Week Range
$23.70
$27.25
Volume
9,579 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Receive NURE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuveen Short-Term REIT ETF and its competitors with MarketBeat's FREE daily newsletter.

Receive NURE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuveen Short-Term REIT ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Nuveen
Fund NameNuveen Short-Term REIT ETF
Tax ClassificationRegulated Investment Company
SymbolBATS:NURE
Inception Date12/19/2016
Fund ManagerPhilip James Campagna, Lei Liao
WebN/A
PhoneN/A

Fund Focus

Asset ClassReal Estate
BenchmarkDow Jones U.S. Select Short-Term REIT Index
CategoryReal Estate
FocusReal Estate
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$117.84 million
Average Daily Volume$24,813.80
Discount/Premium0.01%

ETF Expenses

Management Fee0.35%
Other Expenses0.00%
Total Expenses0.35%
Fee Waiver0.00%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorBrown Brothers Harriman & Co.
AdvisorNuveen Fund Advisors, LLC
CustodianBrown Brothers Harriman & Co.
DistributorNuveen Securities, LLC
Transfer AgentBrown Brothers Harriman & Co.
Trustee
Lead Market MakerLatour Trading

Geographic Exposure of NURE

Currency Exposure of NURE

Sector Exposure of NURE

Industry Exposure of NURE














NURE Stock - Frequently Asked Questions

How has Nuveen Short-Term REIT ETF's stock price performed in 2022?

Nuveen Short-Term REIT ETF's stock was trading at $40.74 at the beginning of 2022. Since then, NURE stock has decreased by 14.2% and is now trading at $34.95.
View the best growth stocks for 2022 here
.

What other stocks do shareholders of Nuveen Short-Term REIT ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nuveen Short-Term REIT ETF investors own include Walt Disney (DIS), Cedar Realty Trust (CDR), Coherent (COHR), Costco Wholesale (COST), Franco-Nevada (FNV), Gulfport Energy (GPOR), The Goldman Sachs Group (GS), Johnson & Johnson (JNJ), Pampa Energía (PAM) and Pinnacle Entertainment (PNK).

What is Nuveen Short-Term REIT ETF's stock symbol?

Nuveen Short-Term REIT ETF trades on the BATS under the ticker symbol "NURE."

Who are Nuveen Short-Term REIT ETF's major shareholders?

Nuveen Short-Term REIT ETF's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include GW Henssler & Associates Ltd. (0.00%), Gradient Investments LLC (0.00%), Saxon Interests Inc. (0.00%), Hedeker Wealth LLC (0.00%), Van ECK Associates Corp (0.00%) and AE Wealth Management LLC (0.00%).

How do I buy shares of Nuveen Short-Term REIT ETF?

Shares of NURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nuveen Short-Term REIT ETF's stock price today?

One share of NURE stock can currently be purchased for approximately $34.95.

This page (BATS:NURE) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.